Parkwood LLC Tg Therapeutics, Inc. Transaction History

Parkwood LLC

$804 Million
Q2 2024

A detailed history of Parkwood LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Parkwood LLC holds 147,680 shares of TGTX stock, worth $3.37 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

147,680

Previous 16,071 818.92%

Holding current value

$3.37 Million

Previous $8.63 Million 14.13%

% of portfolio

1.22%

Previous 0.78%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $1.75 Million - $2.53 Million	131,609 Added 818.92%	147,680 $9.85 Million
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $107,753 - $176,278	-8,276 Reduced 33.99%	16,071 $8.63 Million
Q4 2023 Feb 14, 2024	SELL	$6.68 - $18.81 $942,327 - $2.65 Million	-141,067 Reduced 85.28%	24,347 $1.88 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $1.38 Million - $4.38 Million	165,414 New	165,414 $6.08 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $55,661 - $105,228	-5,441 Reduced 20.26%	21,415 $531,000
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $7.23 Million - $17.1 Million	-1,442,427 Reduced 98.17%	26,856 $5.5 Million
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $6.5 Million - $11.9 Million	1,422,115 Added 3015.0%	1,469,283 $10.7 Million
Q2 2022 Aug 15, 2022	SELL	$3.74 - $10.66 $10,314 - $29,400	-2,758 Reduced 5.52%	47,168 $47,000
Q1 2022 May 13, 2022	BUY	$7.81 - $20.45 $362,430 - $949,002	46,406 Added 1318.35%	49,926 $4.69 Million
Q4 2021 Feb 11, 2022	SELL	$15.2 - $35.51 $559,375 - $1.31 Million	-36,801 Reduced 91.27%	3,520 $4.85 Million
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $291,808 - $541,949	13,398 Added 49.76%	40,321 $5.15 Million
Q2 2021 Aug 13, 2021	SELL	$32.5 - $48.96 $164,190 - $247,345	-5,052 Reduced 15.8%	26,923 $1.89 Million
Q1 2021 May 14, 2021	BUY	$41.61 - $54.3 $20,888 - $27,258	502 Added 1.6%	31,975 $1.54 Million
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $795,322 - $1.73 Million	31,473 New	31,473 $1.64 Million

Others Institutions Holding TGTX

# of Institutions

288

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.32B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.

Account